Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Dec-23
- 19-Sep-24
- 17-Oct-24
- 14-Nov-24
- 21-Nov-24
Select bar for recommendation details.
Recommendations | 21-Nov-24 | |
---|---|---|
Buy | 2 | |
Outperform | 4 | |
Hold | 1 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 6 analysts offering 12 month price targets for Neuropace Inc have a median target of 16.00, with a high estimate of 20.00 and a low estimate of 8.00. The median estimate represents a 77.78% increase from the last price of 9.00.
High | 122.2% | 20.00 |
Med | 77.8% | 16.00 |
Low | -11.1% | 8.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Mar 03, 2025.
Average growth rate | +6.10% |
Average growth rate | +22.74% |
More ▼
Revenue history & estimates in USD
Average growth rate | +6.47% |
Average growth rate | +22.23% |
More ▼